Envisagenics

www.envisagenics.com
30-02 48th Ave, Suites 140 & 150
New York, NY 11101

Company Info

Year Established
2013

Contacts

Maria Luisa Pineda, PhD
Co-Founder & CEO

Martin Akerman, PhD
Co-Founder & CTO

Company Description

Envisagenics is an Artificial Intelligence-driven biotechnology company that focuses on the discovery of novel RNA splicing variants that cause cancer and other genetic diseases.